dreamproit/uscode huggingface dataset:
21 U.S.C. § 1533 (FOOD AND DRUGS)
§ 1533. Information collection and dissemination with respect to grant recipients
(a) Coalition information
(1) General auditing authority
For the purpose of audit and examination, the Administrator—
(A) shall have access to any books, documents, papers, and records that are pertinent to any grant or grant renewal request under this subchapter; and
(B) may periodically request information from a grant recipient to ensure that the grant recipient meets the applicable criteria under section 1532(a) of this title.
(2) Application process
The Administrator shall issue a request for proposal regarding, with respect to the grants awarded under section 1532 of this title, the application process, grant renewal, and suspension or withholding of renewal grants. Each application under this paragraph shall be in writing and shall be subject to review by the Administrator.
(3) Reporting
The Administrator shall, to the maximum extent practicable and in a manner consistent with applicable law, minimize reporting requirements by a grant recipient and expedite any application for a renewal grant made under this part.
(b) Data collection and dissemination
(1) In general
The Administrator may collect data from—
(A) national substance abuse organizations that work with eligible coalitions, community anti-drug coalitions, departments or agencies of the Federal Government, or State or local governments and the governing bodies of Indian tribes; and
(B) any other entity or organization that carries out activities that relate to the purposes of the Program.
(2) Activities of Administrator
The Administrator may—
(A) evaluate the utility of specific initiatives relating to the purposes of the Program;
(B) conduct an evaluation of the Program; and
(C) disseminate information described in this subsection to—
(i) eligible coalitions and other substance abuse organizations; and
(ii) the general public.
(3) Consultation
The Administrator shall carry out activities under this subsection in consultation with the Advisory Commission and the National Community Antidrug Coalition Institute.
(4) Limitation on use of certain funds for evaluation of Program
Amounts for activities under paragraph (2)(B) may not be derived from amounts under section 1524(a) of this title except for amounts that are available under section 1524(b) of this title for administrative costs.
(Pub. L. 100–690, title I, § 1033, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 230; amended Pub. L. 107–82, § 1(e), (f), Dec. 14, 2001, 115 Stat. 818.)
heading: Amendments
text: 2001—Subsec. (b)(3). Pub. L. 107–82, § 1(e), added par. (3).
Subsec. (b)(4). Pub. L. 107–82, § 1(f), added par. (4).
21 U.S.C. § 1534 (FOOD AND DRUGS)
§ 1534. Technical assistance and training
(a) In general
(1) Technical assistance and agreements
With respect to any grant recipient or other organization, the Administrator may—
(A) offer technical assistance and training; and
(B) enter into contracts and cooperative agreements.
(2) Coordination of programs
The Administrator may facilitate the coordination of programs between a grant recipient and other organizations and entities.
(b) Training
The Administrator may provide training to any representative designated by a grant recipient in—
(1) coalition building;
(2) task force development;
(3) mediation and facilitation, direct service, assessment and evaluation; or
(4) any other activity related to the purposes of the Program.
(Pub. L. 100–690, title I, § 1034, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 231.)
21 U.S.C. § 1541 (FOOD AND DRUGS)
§ 1541. Establishment of Advisory Commission
(a) Establishment
There is established a commission to be known as the “Advisory Commission on Drug-Free Communities”.
(b) Purpose
The Advisory Commission shall advise, consult with, and make recommendations to the Director concerning matters related to the activities carried out under the Program.
(Pub. L. 100–690, title I, § 1041, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 231.)
21 U.S.C. § 1542 (FOOD AND DRUGS)
§ 1542. Duties
(a) In general
The Advisory Commission—
(1) shall, not later than 30 days after its first meeting, make recommendations to the Director regarding the selection of an Administrator;
(2) may make recommendations to the Director regarding any grant, contract, or cooperative agreement made by the Program;
(3) may make recommendations to the Director regarding the activities of the Program;
(4) may make recommendations to the Director regarding any policy or criteria established by the Director to carry out the Program;
(5) may—
(A) collect, by correspondence or by personal investigation, information concerning initiatives, studies, services, programs, or other activities of coalitions or organizations working in the field of substance abuse in the United States or any other country; and
(B) with the approval of the Director, make the information referred to in subparagraph (A) available through appropriate publications or other methods for the benefit of eligible coalitions and the general public; and
(6) may appoint subcommittees and convene workshops and conferences.
(b) Recommendations
If the Director rejects any recommendation of the Advisory Commission under subsection (a)(1) of this section, the Director shall notify the Advisory Commission in writing of the reasons for the rejection not later than 15 days after receiving the recommendation.
(c) Conflict of interest
A member of the Advisory Commission shall recuse himself or herself from any decision that would constitute a conflict of interest.
(Pub. L. 100–690, title I, § 1042, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 231.)
21 U.S.C. § 1543 (FOOD AND DRUGS)
§ 1543. Membership
(a) In general
The President shall appoint 11 members to the Advisory Commission as follows:
(1) four members shall be appointed from the general public and shall include leaders—
(A) in fields of youth development, public policy, law, or business; or
(B) of nonprofit organizations or private foundations that fund substance abuse programs.
(2) four members shall be appointed from the leading representatives of national substance abuse reduction organizations, of which no fewer than three members shall have extensive training or experience in drug prevention.
(3) three members shall be appointed from the leading representatives of State substance abuse reduction organizations.
(b) Chairperson
The Advisory Commission shall elect a chairperson or co-chairpersons from among its members.
(c) Ex officio members
The ex officio membership of the Advisory Commission shall consist of any two officers or employees of the United States that the Director determines to be necessary for the Advisory Commission to effectively carry out its functions.
(Pub. L. 100–690, title I, § 1043, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 232.)
21 U.S.C. § 1544 (FOOD AND DRUGS)
§ 1544. Compensation
(a) In general
Members of the Advisory Commission who are officers or employees of the United States shall not receive any additional compensation for service on the Advisory Commission. The remaining members of the Advisory Commission shall receive, for each day (including travel time) that they are engaged in the performance of the functions of the Advisory Commission, compensation at rates not to exceed the daily equivalent to the annual rate of basic pay payable for grade GS–10 of the General Schedule.
(b) Travel expenses
Each member of the Advisory Commission shall receive travel expenses, including per diem in lieu of subsistence, in accordance with sections 5702 and 5703 of title 5.
(Pub. L. 100–690, title I, § 1044, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 232.)
heading: References in Text
text: Grade GS–10 of the General Schedule, referred to in subsec. (a), is set out under section 5332 of Title 5, Government Organization and Employees.
21 U.S.C. § 1545 (FOOD AND DRUGS)
§ 1545. Terms of office
(a) In general
Subject to subsection (b) of this section, the term of office of a member of the Advisory Commission shall be 3 years, except that, as designated at the time of appointment—
(1) of the initial members appointed under section 1543(a)(1) of this title, two shall be appointed for a term of 2 years;
(2) of the initial members appointed under section 1543(a)(2) of this title, two shall be appointed for a term of 2 years; and
(3) of the initial members appointed under section 1543(a)(3) of this title, one shall be appointed for a term of 1 year.
(b) Vacancies
Any member appointed to fill a vacancy for an unexpired term of a member shall serve for the remainder of the unexpired term. A member of the Advisory Commission may serve after the expiration of such member’s term until a successor has been appointed and taken office.
(Pub. L. 100–690, title I, § 1045, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233.)
21 U.S.C. § 1546 (FOOD AND DRUGS)
§ 1546. Meetings
(a) In general
After its initial meeting, the Advisory Commission shall meet, with the advanced approval of the Administrator, at the call of the Chairperson (or Co-chairpersons) of the Advisory Commission or a majority of its members or upon the request of the Director or Administrator of the Program.
(b) Quorum
Six members of the Advisory Commission shall constitute a quorum.
(Pub. L. 100–690, title I, § 1046, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233.)
21 U.S.C. § 1547 (FOOD AND DRUGS)
§ 1547. Staff
The Administrator shall make available to the Advisory Commission adequate staff, information, and other assistance.
(Pub. L. 100–690, title I, § 1047, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233.)
21 U.S.C. § 1548 (FOOD AND DRUGS)
§ 1548. Termination
The Advisory Commission shall terminate at the end of fiscal year 2007.
(Pub. L. 100–690, title I, § 1048, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 234; amended Pub. L. 107–82, § 3, Dec. 14, 2001, 115 Stat. 820.)
heading: Amendments
text: 2001—Pub. L. 107–82 substituted “2007” for “2002”.
21 U.S.C. § 1603 (FOOD AND DRUGS)
§ 1603. General requirements; applicability; preemption
(a) General requirements
(1) In general
In any civil action covered by this chapter, a biomaterials supplier may—
(A) raise any exclusion from liability set forth in section 1604 of this title; and
(B) make a motion for dismissal or for summary judgment as set forth in section 1605 of this title.
(2) Procedures
Notwithstanding any other provision of law, a Federal or State court in which an action covered by this chapter is pending shall, in connection with a motion under section 1605 or 1606 of this title, use the procedures set forth in this chapter.
(b) Applicability
(1) In general
Except as provided in paragraph (2), this chapter applies to any civil action brought by a claimant, whether in a Federal or State court, on the basis of any legal theory, for harm allegedly caused, directly or indirectly, by an implant.
(2) Exclusion
A civil action brought by a purchaser of a medical device, purchased for use in providing professional health care services, for loss or damage to an implant or for commercial loss to the purchaser—
(A) shall not be considered an action that is subject to this chapter; and
(B) shall be governed by applicable commercial or contract law.
(c) Scope of preemption
(1) In general
This chapter supersedes any State law regarding recovery for harm caused by an implant and any rule of procedure applicable to a civil action to recover damages for such harm only to the extent that this chapter establishes a rule of law applicable to the recovery of such damages.
(2) Applicability of other laws
Any issue that arises under this chapter and that is not governed by a rule of law applicable to the recovery of damages described in paragraph (1) shall be governed by applicable Federal or State law.
(d) Statutory construction
Nothing in this chapter may be construed—
(1) to affect any defense available to a defendant under any other provisions of Federal or State law in an action alleging harm caused by an implant; or
(2) to create a cause of action or Federal court jurisdiction pursuant to section 1331 or 1337 of title 28 that otherwise would not exist under applicable Federal or State law.
(Pub. L. 105–230, § 4, Aug. 13, 1998, 112 Stat. 1523.)
21 U.S.C. § 1606 (FOOD AND DRUGS)
§ 1606. Subsequent impleader of dismissed biomaterials supplier
(a) Impleading of dismissed defendant
A court, upon motion by a manufacturer or a claimant within 90 days after entry of a final judgment in an action by the claimant against a manufacturer, and notwithstanding any otherwise applicable statute of limitations, may implead a biomaterials supplier who has been dismissed from the action pursuant to this chapter if—
(1) the manufacturer has made an assertion, either in a motion or other pleading filed with the court or in an opening or closing statement at trial, or as part of a claim for contribution or indemnification, and the court finds based on the court’s independent review of the evidence contained in the record of the action, that under applicable law—
(A) the negligence or intentionally tortious conduct of the dismissed supplier was an actual and proximate cause of the harm to the claimant; and
(B) the manufacturer’s liability for damages should be reduced in whole or in part because of such negligence or intentionally tortious conduct; or
(2) the claimant has moved to implead the supplier and the court finds, based on the court’s independent review of the evidence contained in the record of the action, that under applicable law—
(A) the negligence or intentionally tortious conduct of the dismissed supplier was an actual and proximate cause of the harm to the claimant; and
(B) the claimant is unlikely to be able to recover the full amount of its damages from the remaining defendants.
(b) Standard of liability
Notwithstanding any preliminary finding under subsection (a) of this section, a biomaterials supplier who has been impleaded into an action covered by this chapter, as provided for in this section—
(1) may, prior to entry of judgment on the claim against it, supplement the record of the proceeding that was developed prior to the grant of the motion for impleader under subsection (a) of this section; and
(2) may be found liable to a manufacturer or a claimant only to the extent required and permitted by any applicable State or Federal law other than this chapter.
(c) Discovery
Nothing in this section shall give a claimant or any other party the right to obtain discovery from a biomaterials supplier at any time prior to grant of a motion for impleader beyond that allowed under section 1605 of this title.
(Pub. L. 105–230, § 7, Aug. 13, 1998, 112 Stat. 1528.)
21 U.S.C. § 1708a (FOOD AND DRUGS)
§ 1708a. Annual report requirement
(a) In general
On or before February 1, 2013, and every 3 years thereafter,,1 the Director shall submit a report to Congress that describes—
(1) the strategy of the national media campaign and whether specific objectives of the campaign were accomplished;
(2) steps taken to ensure that the national media campaign operates in an effective and efficient manner consistent with the overall strategy and focus of the campaign;
(3) plans to purchase advertising time and space;
(4) policies and practices implemented to ensure that Federal funds are used responsibly to purchase advertising time and space and eliminate the potential for waste, fraud, and abuse;
(5) all contracts entered into with a corporation, partnership, or individual working on behalf of the national media campaign;
(6) specific policies and steps implemented to ensure compliance with title IV of this Act;
(7) steps taken to ensure that the national media campaign will secure, to the maximum extent possible, no cost matches of advertising time and space or in-kind contributions that are directly related to the campaign in accordance with title IV of this Act; and
(8) a review and evaluation of the effectiveness of the national media campaign strategy for the past year.
(b) Audit
The Government Accountability Office shall, not later than December 31, 2013, and every 3 years thereafter—
(1) conduct and supervise an audit and investigation relating to the programs and operations of the—
(A) Office; or
(B) certain programs within the Office, including—
(i) the High Intensity Drug Trafficking Areas Program;
(ii) the Counterdrug Technology Assessment Center; or
(iii) the National Youth Anti-drug Media Campaign; and
(2) provide the Director and the appropriate congressional committees with a report containing an evaluation of and recommendations on the—
(A) policies and activities of the programs and operations subject to the audit and investigation;
(B) economy, efficiency, and effectiveness in the administration of the reviewed programs and operations; and
(C) policy or management changes needed to prevent and detect fraud and abuse in such programs and operations.
(Pub. L. 109–469, title II, § 203, Dec. 29, 2006, 120 Stat. 3517; Pub. L. 112–234, § 2(c), Dec. 28, 2012, 126 Stat. 1624.)
heading: References in Text
text: Title IV of this Act, referred to in subsec. (a)(6), (7), is title IV of Pub. L. 109–469, Dec. 29, 2006, 120 Stat. 3525, which amended section 1707 of this title.
heading: Codification
text: Section was enacted as part of the Office of National Drug Control Policy Reauthorization Act of 2006, and not as part of the Office of National Drug Control Policy Reauthorization Act of 1998 which comprises this chapter.
heading: Amendments
text: 2012—Subsec. (a). Pub. L. 112–234, § 2(c)(1), substituted “, 2013, and every 3 years thereafter,” for “of each year” in introductory provisions.
Subsec. (b). Pub. L. 112–234, § 2(c)(2), substituted “not later than December 31, 2013, and every 3 years thereafter—” for “at a frequency of not less than once per year—” in introductory provisions.
21 U.S.C. § 1709 (FOOD AND DRUGS)
§ 1709. Repealed. Pub. L. 109–469, title XI, § 1101(a), Dec. 29, 2006, 120 Stat. 3539
text: Section, Pub. L. 105–277, div. C, title VII, § 710, Oct. 21, 1998, 112 Stat. 2681–689, related to Parents Advisory Council on Youth Drug Abuse.
21 U.S.C. § 1710a (FOOD AND DRUGS)
§ 1710a. Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
(a) Requirement
Each advertisement or other communication paid for by the Office, either directly or through a contract awarded by the Office, shall include a prominent notice informing the target audience that the advertisement or other communication is paid for by the Office.
(b) Advertisement or other communication
In this section, the term “advertisement or other communication” includes—
(1) an advertisement disseminated in any form, including print or by any electronic means; and
(2) a communication by an individual in any form, including speech, print, or by any electronic means.
(Pub. L. 105–277, div. C, title VII, § 712, as added Pub. L. 109–469, title XI, § 1118, Dec. 29, 2006, 120 Stat. 3546.)
heading: Repeal of Section
text: For repeal of section on Sept. 30, 2010, see section 1712 of this title.
heading: Codification
text: Another section 712 of title VII of div. C of Pub. L. 105–277 amended former section 1509 of this title.
21 U.S.C. § 1711 (FOOD AND DRUGS)
§ 1711. Authorization of appropriations
There are authorized to be appropriated to carry out this chapter except activities otherwise specified, to remain available until expended, such sums as may be necessary for each of fiscal years 2006 through 2010.
(Pub. L. 105–277, div. C, title VII, § 714, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 601, Dec. 29, 2006, 120 Stat. 3533.)
heading: Repeal of Section
text: For repeal of section on Sept. 30, 2010, see section 1712 of this title.
heading: References in Text
text: This chapter, referred to in text, was in the original “this title”, meaning title VII of Pub. L. 105–277, div. C, Oct. 21, 1998, 112 Stat. 2681–670, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables.
heading: Amendments
text: 2006—Pub. L. 109–469 substituted “chapter except activities otherwise specified,” for “chapter,” and “2006 through 2010” for “1999 through 2003”.
heading: Appropriations
text: Provisions appropriating funds to carry out activities authorized by the Office of National Drug Control Policy Reauthorization Act of 1998, which enacted this chapter, notwithstanding section 1712 of this title, were contained in the following appropriation acts:
Pub. L. 109–115, div. A, title V, Nov. 30, 2005, 119 Stat. 2475.
Pub. L. 108–447, div. H, title III, Dec. 8, 2004, 118 Stat. 3249, 3250.
Pub. L. 108–199, div. F, title III, Jan. 23, 2004, 118 Stat. 324.
21 U.S.C. § 1712 (FOOD AND DRUGS)
§ 1712. Termination of Office of National Drug Control Policy
(a) In general
Except as provided in subsection (b) of this section, effective on September 30, 2010, this chapter and the amendments made to this chapter are repealed.
(b) Exception
Subsection (a) of this section does not apply to section 713 or the amendments made by that section.
(Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533.)
heading: References in Text
text: This chapter, referred to in subsec. (a), was in the original “this title”, meaning title VII of Pub. L. 105–277, div. C, Oct. 21, 1998, 112 Stat. 2681–670, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables.
Section 713, referred to in subsec. (b), is section 713 of Pub. L. 105–277, div. C, title VII, Oct. 21, 1998, 112 Stat. 2681–693, which amended sections 5312 to 5314 of Title 5, Government Organization and Employees, section 1105 of Title 31, Money and Finance, and section 3021 of Title 50, War and National Defense.
heading: Codification
text: The repeal of this chapter and of the amendments made by this chapter, effective Sept. 30, 2003, by this section, as in effect on Sept. 30, 2003, was not given effect in the Code, to reflect the probable intent of Congress, because of the amendment to this section by Pub. L. 109–469, enacted Dec. 29, 2006, which substituted “September 30, 2010” for “September 30, 2003” as the effective date of the repeal. See 2006 Amendment note below.
heading: Amendments
text: 2006—Pub. L. 109–469 substituted “September 30, 2010, this chapter and the amendments made to this chapter” for “September 30, 2003, this chapter and the amendments made by this chapter”.
21 U.S.C. § 1713 (FOOD AND DRUGS)
§ 1713. Authorization of use of environmentally-approved herbicides to eliminate illicit narcotics crops
The Secretary of State, the Attorney General, the Secretary of Agriculture, the Secretary of Defense, the Director of the Office of National Drug Control Policy, and the Administrator of the Environmental Protection Agency are authorized to support the development and use of environmentally-approved herbicides to eliminate illicit narcotics crops, including coca, cannabis, and opium poppy, both in the United States and in foreign countries.
(Pub. L. 105–277, div. C, title VIII, § 834, Oct. 21, 1998, 112 Stat. 2681–702.)
heading: Codification
text: Section was enacted as part of the Western Hemisphere Drug Elimination Act, and not as part of the Office of National Drug Control Policy Reauthorization Act of 1998 which comprises this chapter.